BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10089909)

  • 1. Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells.
    Botzler C; Ellwart J; Günther W; Eissner G; Multhoff G
    Exp Hematol; 1999 Mar; 27(3):470-8. PubMed ID: 10089909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
    Botzler C; Kolb HJ; Issels RD; Multhoff G
    Int J Cancer; 1996 Mar; 65(5):633-8. PubMed ID: 8598315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3.
    Heesbeen EC; Rijksen G; van Heugten HG; Verdonck LF
    Leuk Res; 1995 Jun; 19(6):417-25. PubMed ID: 7596155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in heat sensitivity between normal and acute myeloid leukemic stem cells: feasibility of hyperthermic purging of leukemic cells from autologous stem cell grafts.
    Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
    Exp Hematol; 2003 May; 31(5):421-7. PubMed ID: 12763141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3.
    Mollinedo F; Martínez-Dalmau R; Modolell M
    Biochem Biophys Res Commun; 1993 Apr; 192(2):603-9. PubMed ID: 8484770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
    Yamazaki T; Sieber F
    Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia.
    Okamoto S; Olson AC; Berdel WE; Vogler WR
    Blood; 1988 Nov; 72(5):1777-83. PubMed ID: 3052629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
    Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
    Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.
    Airiau K; Mahon FX; Josselin M; Jeanneteau M; Turcq B; Belloc F
    Exp Hematol; 2012 May; 40(5):367-78.e2. PubMed ID: 22240609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels.
    Gehrmann M; Pfister K; Hutzler P; Gastpar R; Margulis B; Multhoff G
    Biol Chem; 2002 Nov; 383(11):1715-25. PubMed ID: 12530536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
    Douay L; Hu C; Giarratana MC; Bouchet S; Conlon J; Capizzi RL; Gorin NC
    Blood; 1995 Oct; 86(7):2849-55. PubMed ID: 7670119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
    Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients.
    Hantschel M; Pfister K; Jordan A; Scholz R; Andreesen R; Schmitz G; Schmetzer H; Hiddemann W; Multhoff G
    Cell Stress Chaperones; 2000 Nov; 5(5):438-42. PubMed ID: 11189449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
    Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
    [No Abstract]   [Full Text] [Related]  

  • 17. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.
    Chakraborty PK; Mustafi SB; Ganguly S; Chatterjee M; Raha S
    Cancer Sci; 2008 Jun; 99(6):1109-16. PubMed ID: 18429957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative sensitivity of leukemic (CML) and normal progenitor cells to treatment with the photosensitizer benzoporphyrin derivative and light.
    Jamieson C; Hornby A; Richter A; Mitchell D; Levy J
    J Hematother; 1993; 2(3):383-6. PubMed ID: 7922000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
    Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
    Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
    Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.